Buy Stocks Easy | About Us
June 22, 2021
Buy Stocks Easy | Online Stocks

TGTX


Buy TG Therapeutics, Inc. Stock (symbol: TGTX) Easy Online

Company Name: TG Therapeutics, Inc.

Symbol: TGTX

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2007

TGTX Current Share Price

Today's TGTX ( TG Therapeutics, Inc. ) opening price: $

Yesterday's TGTX ( TG Therapeutics, Inc. ) closing price: $

TG Therapeutics, Inc. Stock ( symbol: TGTX ) Price Chart since IPO (2007):

12 Months TG Therapeutics, Inc. Stock ( symbol: TGTX ) Price Chart

Popular Questions about TG Therapeutics, Inc. Public Stock ( TGTX )

A: TG Therapeutics, Inc. stock symbol (also called stock or share ticker) is TGTX

A: TG Therapeutics, Inc. IPO (Initial Public Offering) took place on 2007

A: TG Therapeutics, Inc.'s stock (TGTX symbol) price at ther IPO (initial Public Offering) was $

Q: Is TGTX stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'TG Therapeutics, Inc. stock (symbol: TGTX) at the beginning of 2019, at the opening share price of $4.1000, with a minimum of $200, by now your shares would be worth $9956 and your profit would be $9756 - SHOW ONLY IF PROFIT.

Buy TG Therapeutics, Inc. Stock Easy Online

TG Therapeutics, Inc. Stock Ticker Price Chart since IPO:





TG Therapeutics, Inc. Stock Price Yesterday



 


TG Therapeutics, Inc. Stock Price – Last Week




 


TG Therapeutics, Inc. Stock Price – Last Month




 


TG Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://seekingalpha.com/article/4313035-revisiting-tg-therapeutics
                            

                                
Revisiting TG Therapeutics

                                
                                
With two pivotal data readouts and potentially three NDA filings co...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305863-tg-therapeutics-inc-tgtx-ceo-michael-weiss-q3-2019-results-earnings-call-transcript
                            

                                
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q3 2019 Results - Earnings Call Transcript

                                
                                
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q3 2019 Results -...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305352-tg-therapeutics-deliver-rich-promise
                            

                                
TG Therapeutics Could Be About To Deliver On Rich Promise

                                
                                
TG Therapeutics Could Be About To Deliver On Rich Promise


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1934886/0/en/TG-Therapeutics-Announces-Final-Long-Term-Results-from-the-Phase-3-GENUINE-Study-Demonstrated-that-Ublituximab-in-Combination-with-Ibrutinib-Improved-Progression-Free-Survival-in-P.html
                            

                                
TG Therapeutics Announces Final Long-Term Results from the Phase 3 GENUINE Study Demonstrated that Ublituximab in Combination with Ibrutinib Improved Progression-Free Survival in Patients with High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia as 

                                
                                
Combination was well tolerated with no new safety signals identifie...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/10/22/is-tg-therapeutics-a-buy.aspx
                            

                                
Is TG Therapeutics a Buy?

                                
                                
The company has given back most of its 2019 gains, but does this ch...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1923976/0/en/TG-Therapeutics-to-Present-at-the-2019-Cantor-Global-Healthcare-Conference.html
                            

                                
TG Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

                                
                                
Presentation scheduled for today, Wednesday, October 2, 2019 at 4:1...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/685854/tg-therapeutics-tgtx-catches-eye-stock-jumps-89
                            

                                
TG Therapeutics (TGTX) Catches Eye: Stock Jumps 8.9%

                                
                                
TG Therapeutics (TGTX) saw a big move last session, as its shares j...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/23/1964030/0/en/TG-Therapeutics-Announces-50-0-Million-Registered-Direct-Public-Offering-of-Common-Stock-to-a-Single-Institutional-Investor.html
                            

                                
TG Therapeutics Announces $50.0 Million Registered Direct Public Offering of Common Stock to a Single Institutional Investor

                                
                                
Company anticipates ending 2019 with approximately $140 million in ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4313035-revisiting-tg-therapeutics
                            

                                
Revisiting TG Therapeutics

                                
                                
With two pivotal data readouts and potentially three NDA filings co...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305863-tg-therapeutics-inc-tgtx-ceo-michael-weiss-q3-2019-results-earnings-call-transcript
                            

                                
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q3 2019 Results - Earnings Call Transcript

                                
                                
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q3 2019 Results -...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305352-tg-therapeutics-deliver-rich-promise
                            

                                
TG Therapeutics Could Be About To Deliver On Rich Promise

                                
                                
TG Therapeutics Could Be About To Deliver On Rich Promise


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.